Use of bluetongue virus proteins as vaccine components

Details Use of bluetongue virus proteins as vaccine components Use of bluetongue virus proteins as vaccine components

C - Chemistry, Metallurgy

12

N

C12N 15/46 (2006.01) A61K 39/15 (2006.01) C07K 14/14 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2075945

2075945 9100741 PCTABS00003 A protective effect against bluetongue infection in susceptible mammals which is obtained by inoculating said mammals with a polypeptide comprising at least an antigenic portion of bluetongue virus structural protein VP2 in antigenic form produced by transforming a host with a recombinant expression vector having a DNA segment coding for said polypeptide.

Affiliated with

Also associated with

Rating

Use of bluetongue virus proteins as vaccine components does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of bluetongue virus proteins as vaccine components, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bluetongue virus proteins as vaccine components will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1890364